<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1535539</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Exploration of the primary antibiofilm substance and mechanism employed by <italic>Lactobacillus salivarius</italic> ATCC 11741 to inhibit biofilm of <italic>Streptococcus mutans</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Nan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2881278"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Bairu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bao</surname>
<given-names>Meihua</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Yimin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Meng</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xiaopeng</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Junyi</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Chengyue</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2920172"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Qiu</surname>
<given-names>Lihong</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Periodontics, Affiliated Stomatology Hospital of Jinzhou Medical University</institution>, <addr-line>Jinzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Collaborative Innovation Center for Health Promotion of Children and Adolescents of Jinzhou Medical University</institution>, <addr-line>Jinzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pedodontics, Affiliated Stomatology Hospital of Jinzhou Medical University</institution>, <addr-line>Jinzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Prosthetics, Affiliated Stomatology Hospital of Jinzhou Medical University</institution>, <addr-line>Jinzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Jinzhou Medical University</institution>, <addr-line>Jinzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Endodontics, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases</institution>, <addr-line>Shenyang</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Keke Zhang, Wenzhou Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Wei Qiu, Southern Medical University, China</p>
<p>Yujie Zhou, Sichuan University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Chengyue Wang, <email xlink:href="mailto:wangcy@jzmu.edu.cn">wangcy@jzmu.edu.cn</email>; Lihong Qiu, <email xlink:href="mailto:lhqiu@cmu.edu.cn">lhqiu@cmu.edu.cn</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>03</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1535539</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>11</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>01</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Ma, Yang, Chen, Bao, Li, Wang, Yang, Liu, Wang and Qiu</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Ma, Yang, Chen, Bao, Li, Wang, Yang, Liu, Wang and Qiu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>
<italic>Lactobacillus salivarius</italic> serves as a probiotic potentially capable of preventing dental caries both <italic>in vitro</italic> and <italic>in vivo</italic>. This study focused on understanding the key antibiofilm agents and the mechanisms of action of the <italic>Lactobacilli</italic> supernatant against <italic>Streptococcus mutans</italic>.</p>
</sec>
<sec>
<title>Methods</title>
<p>
<italic>Streptococcus mutans</italic> biofilm was constructed and the cell-free supernatant of <italic>Lactobacillus salivarius</italic> was added. After the biofilm was collected, RNA-seq and qRT-PCR were then performed to get gene information. The influence of temperature, pH and other factors on the supernatant were measured and non-targeted metabolome analysis was performed to analyze the effective components.</p>
</sec>
<sec>
<title>Results</title>
<p>The findings indicated that the supernatant derived from <italic>Lactobacillus salivarius</italic> could inhibit the biofilm formation of <italic>Streptococcus</italic> mutans at different times. Through transcriptome analysis, we discovered that the cell-free supernatant reduced biofilm formation, by suppressing phosphoenolpyruvate-dependent phosphotransferase systems along with two ATP-binding cassette transporters, rather than directly affecting the genes that code for glucosyltransferases; additionally, the supernatant was observed to diminish the expression of genes linked to two-component systems, polyketides/non-ribosomal peptides, acid stress response, quorum sensing, and exopolysaccharide formation. Non-targeted LC-MS/MS analysis was employed to discover a variety of potential active compounds present in the cellular filtrate of <italic>Lactobacillus salivarius</italic> that hinder the growth of S. mutans, including phenyllactic acid, sorbitol, and honokiol.</p>
</sec>
<sec>
<title>Discussion</title>
<p>In summary, our findings support the evaluation of <italic>Lactobacillus salivarius</italic> as a promising oral probiotic aimed at hindering the formation of biofilms by cariogenic pathogens and the development of dental caries.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>Streptococcus mutans</italic>
</kwd>
<kwd>transcriptomics</kwd>
<kwd>metabolomics</kwd>
<kwd>biofilm</kwd>
<kwd>dental caries</kwd>
<kwd>
<italic>Lactobacillus salivarius</italic>
</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="46"/>
<page-count count="14"/>
<word-count count="6853"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Biofilms</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Oral health is intricately connected to overall wellbeing. The World Health Organization explicitly identifies oral health as one of the 10 essential components of human health. Dental caries is a common oral condition that poses significant risks to public health. Its condition is a chronic and progressive disease that stems from dental plaques housing cariogenic microorganisms and characterized by demineralization of inorganic substance and decomposition of organics (<xref ref-type="bibr" rid="B19">Lin et&#xa0;al., 2022</xref>).</p>
<p>
<italic>Streptococcus mutans</italic> is a type of Gram-positive bacterium known for its strong ability to metabolize sucrose, generate acids, and contribute to the formation of cariogenic organisms. It is the main colonizing bacteria in the beginning stage of biofilm formation, which is regarded as the main pathogen of dental caries (<xref ref-type="bibr" rid="B17">Li et&#xa0;al., 2020</xref>). Long seen as a common pathogen within the oral&#xa0;microbiome, <italic>S. mutans</italic> was confirmed to be a pivotal microorganism implicated in the progression of dental caries, which utilizes sucrose to produce acid rapidly, creating a local low pH environment to assist the colonization of other cariogenic bacteria, forming a cariogenic biofilm that ultimately generates tooth decay (<xref ref-type="bibr" rid="B36">Wasfi et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B21">Liu et&#xa0;al., 2021</xref>). Cariogenic biofilm is a highly dynamic and structured microbial community, covered by the extracellular polymeric substance (EPS) matrix on its surface, which comprises various polymers such as extracellular polysaccharides, proteins, and nucleic acids (<xref ref-type="bibr" rid="B5">Gao et&#xa0;al., 2023</xref>). The function of EPS in promoting biofilm formation is mainly through the following aspects: adhesion, intercellular aggregation, biofilm cohesion, barrier protection, and nutrient support (<xref ref-type="bibr" rid="B29">Simon-Soro and Mira, 2015</xref>). This complex three-dimensional biofilm structure creates a unique microenvironment that shields microbes from environmental stressors, such as host immune responses and pharmaceuticals, while also preventing the dissemination of acids that can result in enamel demineralization and subsequently promote the development of tooth decay (<xref ref-type="bibr" rid="B8">He et&#xa0;al., 2016</xref>). Meanwhile, the biofilm structure hinders the penetration of drugs, making it difficult for conventional antibacterial agents to exert their effects (<xref ref-type="bibr" rid="B4">Cugini et&#xa0;al., 2019</xref>).</p>
<p>Traditional preventive and therapeutic strategies for dental caries primarily involve mechanical interventions, antibiotics, natural plant extract therapy, and the administration of fluoride (<xref ref-type="bibr" rid="B1">Alshahrani and Gregory, 2020</xref>; <xref ref-type="bibr" rid="B30">Sun et&#xa0;al., 2021</xref>). However, each of these methods has its limitations (<xref ref-type="bibr" rid="B6">Guo et&#xa0;al., 2015</xref>). Mechanical therapy is limited by human will and the effect is superficial. Numerous antibiotics may disrupt the natural balance of the bacterial community, which can lead to enhanced resistance among pathogenic bacteria. Moreover, excessive fluorine usage may result in chronic fluorosis. Consequently, seeking more efficient, quick, and safe approaches to inhibit bacterial biofilm formation is essential.</p>
<p>Probiotics, defined as live microorganisms, are known to offer health advantages to hosts when consumed in appropriate quantities (<xref ref-type="bibr" rid="B41">Yeun and Lee, 2015</xref>). Currently, <italic>Lactobacillus</italic> is the most studied and applied probiotics. Long-term studies found that <italic>Lactobacillus</italic> could prevent caries by producing metabolites including lactic acid, peroxide, bacteriocin, and proteinaceous compounds, impeding adhesion and colonization, and being effective in downregulating the expressions of virulence genes linked to biofilm formation (<xref ref-type="bibr" rid="B37">Wasfi et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B46">Zhao et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B45">Zhang et&#xa0;al., 2024</xref>).</p>
<p>The cell-free supernatant (CFS) of microbial culture medium is the metabolites produced during microbial growth and residual nutrients in the culture medium. Studies have shown that substances that exert an antibacterial effect in the CFS include lactic acid, acetic acid, hydrogen peroxide, long-chain fatty acids and their esters, and protein compounds (<xref ref-type="bibr" rid="B34">van Zyl et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B23">Mani-Lopez et&#xa0;al., 2022</xref>). It was reported that the CFS of <italic>Lactobacillus rhamnosus</italic> contained small cyclic peptides that could inhibit the biofilm formation of <italic>S. mutans</italic> (<xref ref-type="bibr" rid="B25">Niranjan et&#xa0;al., 2024</xref>).</p>
<p>
<italic>Lactobacillus salivarius</italic> is commonly found in human saliva, characterized by its ability to generate organic acids through carbohydrate fermentation, which inhibits the proliferation of surrounding microbes (<xref ref-type="bibr" rid="B13">K&#xf5;ll-Klais et&#xa0;al., 2005</xref>). Because of this antagonistic property, numerous studies have revealed that they could be used to treat periodontal disease and peri-implant diseases, control body weight, and improve the host immunity (<xref ref-type="bibr" rid="B24">Mulla et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B3">Chen et&#xa0;al., 2022</xref>).</p>
<p>The limited number of studies about the specific mechanism of the probiotic <italic>L. salivarius</italic> against <italic>S. mutans</italic> in cariogenic biofilms prompted us to address this problem. Therefore, this article aimed to evaluate the influence of the <italic>L. salivarius</italic> ATCC11741 supernatant on cariogenic biofilms, explore the potential mechanisms through the supernatant that may intervene in cariogenic biofilms, analyze the functional substances of the supernatant, and evaluate the effect of anti-caries in animal models.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Bacterial strains and culture conditions</title>
<p>Strains of <italic>S. mutans</italic> (ATCC 25175) and <italic>L. salivarius</italic> (ATCC 11741) were sourced from the China General Microbiological Culture Collection Center (CGMCC; Beijing, China). <italic>L. salivarius</italic> was grown in de Man&#x2013;Rogosa&#x2013;Sharpe (MRS) broth and <italic>S. mutans</italic> was cultured with brain&#x2013;heart infusion (BHI) broth at 37&#xb0;C under aerobic and microaerophilic conditions, with all strains stored in the broth containing 30% glycerol at &#x2212;80&#xb0;C routinely and were subsequently incubated on appropriate agar plates for 24&#xa0;h, followed by 2% (v/v) inoculation in the relevant broth at 37&#xb0;C for an additional 18&#xa0;h before experimental use.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Preparation of cell-free supernatant</title>
<p>The CFS of <italic>L. salivarius</italic> was manufactured following a modified protocol established by Liang (<xref ref-type="bibr" rid="B18">Liang et&#xa0;al., 2023</xref>). In summary, <italic>L. salivarius</italic> was regulated to a concentration of 1&#xd7;10<sup>7</sup> CFU/mL during the late logarithmic growth phase and subsequently incubated for 24&#xa0;h at 37&#xb0;C. After the bacterial culture, the spent culture underwent centrifugation (5,000&#xd7;<italic>g</italic>, 10&#xa0;min, 4&#xb0;C), and the obtained supernatant was further filtered with a 0.22-&#xb5;m filter to acquire the CFS.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Biofilm formation assay</title>
<p>An overnight culture of <italic>S. mutans</italic> was diluted to a predetermined final concentration of 1.0&#xd7;10<sup>6</sup> CFU/mL in BHI broth enriched with 1% sucrose. This diluted culture was then dispensed into a 96-well microtiter plate at a volume of 200 &#x3bc;L, either with or without the increase of CFS, and incubated for 24&#xa0;h. The final CFS concentrations, both treated and untreated, ranged from 12.5% to 100% (v/v). For different time treatment, a certain amount of CFS was added into the 96-well microtiter plate at 0, 6, and 12&#xa0;h, respectively, at 37&#xb0;C for 24&#xa0;h. The method of mediating the biofilm by CFS at 24&#xa0;h was as follows: 200 &#x3bc;L of suspension of <italic>S. mutans</italic> was added to each well of a 96-well plate and then cultured for 24&#xa0;h, the biofilm was washed with phosphate-buffered saline (PBS) two times, and then 100 &#x3bc;L of CFS was added and the culture was continued for another 24&#xa0;h. A crystal violet staining assay was conducted to evaluate how effectively the CFS inhibited biofilm formation by <italic>S. mutans</italic> (<xref ref-type="bibr" rid="B37">Wasfi et&#xa0;al., 2018</xref>). Specifically, after removing the culture supernatant, the biofilm was washed with PBS and fixed in methanol for 30&#xa0;min. Afterward, the wells were stained with 0.1% crystal violet solution for 30&#xa0;min, and then dissolved in 33% glacial acetic acid over 30&#xa0;min until fully solubilized. Finally, optical densities were recorded at 575 nm using a microplate reader (the amount of biofilm formation). As a negative control, CFS was replaced by MRS broth.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Biofilm microstructure observed using scanning electron microscopy</title>
<p>An overnight culture of <italic>S. mutans</italic> was maintained in BHI broth and subsequently diluted to 1.0&#xd7;10<sup>7</sup> CFU/mL (with 1% sucrose). A sterile cover slide was placed into the wells of a 24-well plate. In each well, 800 &#x3bc;L of the <italic>S. mutans</italic> suspension was combined with 160 &#x3bc;L of CFS or MRS broth and incubated under anaerobic conditions for 24&#xa0;h. The cover slides were carefully rinsed three times using PBS, fixed, and prepared for scanning electron microscopy (SEM) observation (Hitachi, SU8100) following an established protocol (<xref ref-type="bibr" rid="B21">Liu et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Fluorescence staining for observing the proportion of live and dead bacteria in biofilm</title>
<p>Suspensions (1.75 mL) and 350 &#x3bc;L of CFS were added into the confocal dishes and cultured at 37&#xb0;C for 24&#xa0;h. The biofilm was subjected to staining for 30&#xa0;min and subsequently observed using a confocal laser scanning microscope (CLSM) according to the BBcell Probe&#x2122; live/dead bacterial staining kit. In the control conditions, MRS broth served as a substitute for the CFS.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Physical and chemical properties of active components in CFS</title>
<sec id="s2_6_1">
<label>2.6.1</label>
<title>Temperature stability</title>
<p>The CFS was treated at 50&#xb0;C, 60&#xb0;C, 70&#xb0;C, 80&#xb0;C, 90&#xb0;C, and 100&#xb0;C for 30&#xa0;min in a dry thermostatic metal bath, respectively. The activity of inhibiting biofilm formation mediated by these CFSs was compared.</p>
</sec>
<sec id="s2_6_2">
<label>2.6.2</label>
<title>pH and enzymatic stability</title>
<p>The pH of the supernatant was adjusted to 6.5 using 1 mol/L NaOH, maintained for 1&#xa0;h, and then readjusted to the initial pH value (3.9) with 1 mol/L HCl. In addition, 5 mg/mL of catalase and 1 mg/mL of proteinase K (Solarbio, Beijing, China) were added to the CFS for enzymatic stability. Untreated CFS was used as control.</p>
</sec>
<sec id="s2_6_3">
<label>2.6.3</label>
<title>Non-targeted metabolome analysis</title>
<p>CFS and MRS culture medium were respectively divided into six biological replicates for LC-MS analysis conducted by Majorbio (Majorbio Biotech Co., Ltd., Shanghai, China) for non-targeted metabolomic evaluation, in accordance with the method depicted in the literature with minor modifications (<xref ref-type="bibr" rid="B10">Hou et&#xa0;al., 2021</xref>). A volume of 200 &#x3bc;L of the sample underwent ultrasonication and was obtained using 800 &#x3bc;L of mixture of methanol and acetonitrile (1:1, v/v) that contained an internal standard and subjected to ultrasonication at 40 kHz (5&#xb0;C, 30&#xa0;min). The samples were frozen at &#x2212;20&#xb0;C for half an hour, centrifuged for 15&#xa0;min, and then evaporated with a stream of N2 gas. The resultant samples were reconstituted in 120 &#x3bc;L of an acetonitrile:water solution (1:1, v/v) and were ultrasonicated again at 40 kHz (5&#xb0;C, 10&#xa0;min). After being centrifugated at 13,000&#xd7;<italic>g</italic> (4&#xb0;C, 10&#xa0;min), we transferred the obtained supernatants into sample bottles in preparation for subsequent LC-MS/MS analysis. Furthermore, to maintain analytic stability, quality control (QC) samples were created by merging 20 &#x3bc;L of specimen from every sample.</p>
<p>The analysis was conducted via LC-MS/MS utilizing the UHPLC-Q Exactive HF-X system (Thermo Fisher, Waltham, MA, USA). Progenesis QI v3.0 was employed for processing the raw data (Waters Corporation, Milford, USA). To enhance the distinctions among the groups and identify variables of class separation, a supervised clustering method known as partial least squares discriminant analysis (PLS-DA) was implemented. We calculated variable importance in the projection (VIP) values to demonstrate the roles of different variables within the PLS-DA model. The metabolites were annotated according to KEGG for the analysis of metabolic pathways as well as for the classification of compounds. The differential metabolites were categorized using the HMDB database. A difference in metabolite production between the two groups was considered significant if <italic>p</italic> &lt; 0.05 and VIP &gt; 1.</p>
</sec>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Transcriptome analysis by RNA-seq</title>
<p>
<italic>S. mutans</italic> were cultured statically in six-well polystyrene plates for 24&#xa0;h, allowing loosely attached bacterial cells to be gently rinsed off and then the biofilms were scraped off and approximately 50 mg of biofilm mass was collected by centrifugation and frozen at&#x2009;&#x2212;80&#xb0;C until used. Library construction, sequencing, and analysis services were provided by GENEWIZ Life Sciences (Suzhou, China). Each group for transcriptomics had three replicates. The data presented in the study are deposited in the NCBI repository, accession number PRJNA1219341.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Total bacterial RNA extraction and quantitative real-time polymerase chain reaction</title>
<p>The biofilm formation assay adopted the same preparation as before. Following incubation, the culture suspension from the wells was discarded. The plate wells underwent two washes with sterile saline, after which biofilm was scraped and suspended in saline for transfer to a centrifuge tube. The RNAprep pure Cell/Bacteria Kit (Tiangen Biotech; Beijing; China) was used for total RNA extraction according to the instructions of this kit. RNA concentration and purity were assessed using the ND-1000 spectrophotometer. Primer [Sangon Biotech Company (Shanghai, China)] sequences are listed in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. The RNA was reversely transcribed into cDNA with the NovoScript Plus All-in-one 1st Strand cDNA Synthesis SuperMix (gDNA Purge) kit (Novoprotein, E047, Suzhou, China), subsequently utilizing the NovoStart SYBR qPCR SuperMix Plus reagent (Novoprotein, E096, Suzhou, China). The internal reference was 16S rRNA. The gene transcription level was evaluated using the 2<sup>&#x2212;&#x394;&#x394;CT</sup> methodology.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>The table of primer sequences.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Primers</th>
<th valign="middle" align="center">Sequences (5&#x2032;&#x2013;3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">16S rRNA</td>
<td valign="middle" align="left">F: CCTACGGGAGGCAGCAGTAG<break/>R: CAACAGAGCTTTACGATCCGAAA</td>
</tr>
<tr>
<td valign="middle" align="center">LrgB</td>
<td valign="middle" align="left">F: GGCAAAAGGATTGGGAACTGATG<break/>R: TGGAACGGCAAAGGCAATGG</td>
</tr>
<tr>
<td valign="middle" align="center">DexA</td>
<td valign="middle" align="left">F: AGGGCTGACTGCTTCTGGAGT<break/>R: AGTGCCAAGACTGACGCTTTG</td>
</tr>
<tr>
<td valign="middle" align="center">Ldh</td>
<td valign="middle" align="left">F: TCCTGTTGGAGGTGGCATTC<break/>R: TGCTGTACCCGCATTCCATT</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Inhibitory effect of <italic>L. salivarius</italic> on <italic>S. mutans</italic> virulence <italic>in vivo</italic>
</title>
<sec id="s2_9_1">
<label>2.9.1</label>
<title>Animals and general procedures</title>
<p>The design of animal experiments was similar to the description by previous literature (<xref ref-type="bibr" rid="B44">Zhang et&#xa0;al., 2020</xref>). The flowchart of the animal model is shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>. Male SPF Sprague&#x2013;Dawley rats (18 days old) were bought from the Jinzhou Medical University experiment animal center. The experiment received approval from the school&#x2019;s Animal Protection and Institutional Committee (approval number: 230078) in accordance with the national animal protection guidelines. All laboratory animals were operated on under anesthesia and all efforts were made to reduce pain, suffering, and mortality. A total of four groups of rats (<italic>n</italic> = 3) were randomly assigned, including two treatment groups (<italic>L. salivarius</italic> suspension and CFS), as well as the caries-free and caries model groups. The rats in the caries-free group were given normal diet and distilled water during the whole experiment. Other groups were offered a cariogenic diet 2000 (obtained from Jiangsu Xietong Pharmaceutical Bio-engineering Co., Ltd.) and water containing 5% sucrose. To suppress the oral bacteria group, 0.5 &#x3bc;g/mL of ampicillin and 200 &#x3bc;g/mL of streptomycin were administered for 3 days prior to modeling. Over a period of 5 days starting at the experiment&#x2019;s commencement, three groups of rats used for caries modeling were infected with <italic>S. mutans</italic>. This was achieved by saturating sterile cotton swabs with 1 mL of an <italic>S. mutans</italic> culture (10<sup>8</sup> CFU/mL) and applying the suspension into each quadrant of the rat&#x2019;s mouth for 15 s. After the application of the tooth coating, dietary and water access was restricted for 2&#xa0;h to facilitate the colonization of the microorganisms. At the age of 27, 100 &#x3bc;L of saliva was collected and coated on a plate for culture for detecting the colonization of <italic>S. mutans</italic> and recording the colony-forming units (CFU) for verifying the establishment of tested strains. The treatment groups were then administered 1 mL of <italic>L. salivarius</italic> suspension or CFS one time per day until the experiment&#x2019;s conclusion (from days 28 to 63). The rats&#x2019; weights were recorded weekly, and the weight gain was calculated.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Flowchart of animal model <bold>(A)</bold>. <italic>S. mutans</italic> count from different treatment groups <bold>(B)</bold> ,**<italic>p</italic> &lt; 0.01 significantly different from the caries free group. Data&#xa0;were expressed as mean &#xb1; standard error of the mean (<italic>n</italic> = 3). 3D micro-CT image of mandibular molars, separated enamel (green), and corresponding 2D scale sagittal slice of the same molar (enamel is green) in each group <bold>(C)</bold>. Volume of enamel of mandibular molars <bold>(D)</bold> **<italic>p</italic> &lt; 0.01 significantly different from the caries-model group; ns, not significant. Density of enamel of mandibular molars <bold>(E)</bold>, *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01 significantly different from the caries-model group; ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1535539-g001.tif"/>
</fig>
</sec>
<sec id="s2_9_2">
<label>2.9.2</label>
<title>Micro-CT analysis</title>
<p>After successful modeling, SD rats were euthanized. All the mandibles were harvested, fixed with 4% paraformaldehyde, and then imaged with a VENUS Micro CT instrument (Kunshan, China). 3D pictures were created utilizing AVATAR 1.5.0 software. The enamel was separated from the mandible with fixed thresholds and the mineral density and volume of the enamel were evaluated after correction for hydroxyapatite criteria.</p>
</sec>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Statistical analysis</title>
<p>Each experiment was performed three times, and all results were expressed as mean &#xb1; standard deviation. One-way analysis of variance (ANOVA) was used for statistical analysis along with Dunnett&#x2019;s test through GraphPad Prism version 8.0.1. Subsequently, all pairs of mean comparisons were assessed using the <italic>post-hoc</italic> Tukey method. <italic>p</italic> &lt; 0.05 was considered statistically significant, while <italic>p</italic> &lt; 0.01 was considered highly statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Antibiofilm effect of CFS of <italic>L. salivarius</italic> against <italic>S. mutans</italic>
</title>
<p>As illustrated in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>, all CFSs at varying concentrations demonstrated efficacy in suppressing the biofilm formation of <italic>S. mutans</italic>. Specifically, CFS could inhibit 99% of <italic>S. mutans</italic> biofilm formation when used at concentrations of 50% (v/v). When the CFS was diluted to the concentration of 25%, the effect of biofilm formation decreased to 93.4% (<italic>p</italic> &lt; 0.05). As the CFS was diluted to 12.5%, the inhibition decreased to 28.6% (<italic>p</italic> &lt; 0.01).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Antibiofilm effect of CFS against <italic>S. mutans</italic> <bold>(A)</bold>. Biomass of the biofilm mediated by CFS at different times <bold>(B)</bold>. The data are presented as the means &#xb1;&#xa0;SD. **<italic>p</italic> &lt; 0.01, compared with the control group; ns, not significant. Effect of CSF on the structure of <italic>Streptococcus mutans</italic> biofilm <bold>(C)</bold>. Effect of&#xa0;CSF on the activity of <italic>Streptococcus mutans</italic> biofilm <bold>(D)</bold>. Red, non-viable cells; green, viable cells; yellow, overlap of non-viable and viable cells. Bar = 50 &#x3bc;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1535539-g002.tif"/>
</fig>
<p>The biofilm formation process included four essential time points: 0&#xa0;h, where bacteria initially adhered; 6&#xa0;h, marking the initial colonization of bacteria; 12&#xa0;h, indicating early biofilm development; and 24&#xa0;h, reflecting mature biofilm formation. As <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref> shows, the amount of biofilm mediated by each time point decreased significantly (<italic>p</italic> &lt; 0. 01); the 24-h-mediated biofilm showed a certain reduction in biofilm volume compared with the 24-h control biofilm (<italic>p</italic> &lt; 0.01). The results showed that the CFS of <italic>L. salivarius</italic> had a strong inhibitory effect in the early stage of biofilm formation, but had a slightly destructive effect on middle and mature stage of biofilm formation.</p>
<p>At a dilution of 16.7% for the CFS, the SEM micrograph presented in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref> demonstrated that a compact biofilm typical for <italic>S. mutans</italic> displayed a network-like composition identified as EPS. However, the biofilm architecture of <italic>S. mutans</italic> added with CFS appeared significantly more dispersed, exhibiting fewer micro-colonies on the surface compared to that of <italic>S. mutans</italic> alone, with a decrease in the quantity of EPS. Biofilms were created in the presence of CFS following 24&#xa0;h of cultivation and analyzed by a confocal laser scanning microscope (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>). The images demonstrate fluorescence intensities in green (live bacteria) and red (dead bacteria). The control group revealed that the biofilm was distributed uniformly, accompanied by a comparatively dense structure and total surface coverage. As shown in the CFS treatment group, the biofilms seemed significantly more dispersed and notably looser. The surface area that the biofilm occupied decreased because of CFS, leading to a marked reduction of biofilm biomass.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Analysis of antibiofilm components in CFS</title>
<p>Literature indicated that the antimicrobial components found in the CFS from <italic>Lactobacillus</italic> consist of organic acids, hydrogen peroxide, and bacteriocin (<xref ref-type="bibr" rid="B32">Vahedi Shahandashti et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B22">Liu et&#xa0;al., 2020</xref>). Bacteriocin is a protein synthesized by ribosomes, a metabolite secreted by bacteria during their reproductive process, possessing antibacterial properties (<xref ref-type="bibr" rid="B14">Kumariya et&#xa0;al., 2019</xref>). To preliminarily investigate the characteristics of the primary antibacterial agent, three portions of CFS were exposed to catalase and proteinase K, and pH was adjusted to neutral levels. After being treated with catalase and proteinase K, <italic>S. mutans</italic> showed a reduced but not lost antibiofilm effect. These findings suggested that hydrogen peroxide and a protein-like substance could serve as the principal antibiofilm agent in the CFS of <italic>L. salivarius</italic>. Additionally, this research revealed that the pH of the obtained CFS measured at 3.9. After adjusting the pH to 6.5, the CFS lost its antibiofilm capability; meanwhile, when the pH returned to the original value, the antibiofilm effect of CFS had not been fully restored (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). As a result, we conducted further examinations to identify the main antibiofilm constituents of CFS. After the CFS was treated at different temperatures, there were no notable changes in its ability to inhibit biofilm formation. Even after 30-min treatment at 100&#xb0;C, it still had the effect of inhibiting biofilm, and interestingly, it was slightly increased compared to that without treatment after 80&#xb0;C (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). This indicates that the active components of the CFS were thermally stable.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>The inhibition effect on the biofilm of the CFS after different treatments. pH and enzyme <bold>(A)</bold> and temperature <bold>(B)</bold>. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01 significantly different from the control group; ns, not significant. The metabolites in the CFS group compared to those in the control group. Principal component analysis (PCA) score plot of metabolite profiles from the treated and control groups <bold>(C)</bold>. Partial least squares discriminant analysis (PLS-DA) score plot of metabolite <bold>(D)</bold>. Volcano plot of the metabolites from CFS and control <bold>(E)</bold>. Variable importance for the projection (VIP) score calculated by PLS-DA <bold>(F)</bold>. KEGG compound analyses of upregulated metabolites <bold>(G)</bold>. HMDB compound classification diagram <bold>(H)</bold>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1535539-g003.tif"/>
</fig>
<p>To analyze the effective components of CFS that enforce antibacterial properties, the extracellular metabolite profiles were compared between MRS and CFS through metabolomic analysis following a 24-h incubation period. The principal component analysis (PCA) and PLS-DA models highlighted significant metabolite differences between the two sample groups, all within the 95% confidence interval (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>). In the presence of the CFS, 436 metabolites were upregulated, while 694 were downregulated (<italic>p</italic> &lt; 0.05, VIP &gt; 1) compared with those in the presence of MRS broth (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). There was a significant difference between the fermentation broths before and after cultivation, indicating that effective substances that may inhibit biofilm formation have been produced during the fermentation process. The VIP plots (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>) indicated that certain identified metabolites contributed to class differentiation. KEGG compound analysis of the upregulated metabolites was conducted, mainly including fatty acids, amino acids, nucleotides, and carboxylic acids (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3G</bold>
</xref>). The upregulated metabolites predominantly included various compounds including organic acids and derivatives, lipids and lipid-like substances, organoheterocyclic entities, organic oxygen compounds, and benzenoids were produced, as indicated by the HMDB compound classification analysis (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3H</bold>
</xref>). This section explored the characteristics of the effective components in CFS, which were thermally stable and possible protein and hydrogen peroxide-like substances and have a relatively narrow pH tolerance range, possibly being a type of organic acid or a substance that functions under acidic conditions. Furthermore, by combining with the non-targeted metabolomics method based on LC-MS to identify the differential metabolites between the CFS and the initial culture medium, we found that they were mainly fatty acids, amino acids, nucleotides, and carboxylic acids.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Transcriptome analysis by RNA-seq and analysis of qRT-PCR results</title>
<p>Given that CFS led to notable inhibition of biofilm formation by <italic>S. mutans</italic>, we conducted transcriptome analysis on both <italic>S. mutans</italic> treated with CFS and those under control conditions to monitor genome-wide gene expression alterations caused by CFS.</p>
<p>PCA showed that all biological replicates clustered closely, suggesting that gene expression underwent significant alteration due to CFS treatment compared to untreated controls, accounting for the 81.7% variance observed in the overall dataset (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). The differentially expressed genes (DEGs) were identified using a modified <italic>p</italic>-value threshold of &lt;&#x2009;0.01 observed through the control and CFS groups. As depicted in the volcano plot and heatmap in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>, 487 genes were found to be upregulated, while 519 exhibited downregulation. DEGs were annotated, functionally utilizing KEGG enrichment analysis. The GO enrichment assessment concerning molecular functions, cellular components, and biological processes revealed the involvement of these DEGs in DNA binding, oxidoreductase activity, membrane, <italic>de novo</italic> IMP biosynthetic process, and carbohydrate transport (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). The functional annotation of DEGs was carried out along with KEGG pathway and enrichment analysis (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4D, E</bold>
</xref>). Furthermore, 30 significant KEGG pathways were revealed, demonstrating potential links to the metabolic processes of <italic>S. mutans</italic>, including pathways related to pyruvate metabolism, purine metabolism, amino sugar and nucleotide sugar metabolism, galactose metabolism, and the TCA cycle. Certain pathways, especially pyruvate metabolism, the phosphotransferase system, and ATP-binding cassette (ABC) transporters, play vital roles in biofilm formation.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Effects of CFS through RNA-Seq analysis in <italic>S. mutans</italic> biofilms. Principal component analysis (PCA) score plot from the treated and control groups <bold>(A)</bold>. Volcano plot illustrating genes with significant expression differences of <italic>S. mutans</italic> biofilms in the CFS group <bold>(B)</bold>. GO annotation analysis of differentially expressed genes <bold>(C)</bold>. KEGG pathway analysis of differentially expressed genes <bold>(D)</bold>. KEGG rich analysis of differentially expressed genes <bold>(E)</bold>. Validation of differentially expressed genes using qRT-PCR <bold>(F)</bold> **<italic>p</italic> &lt; 0.01 significantly different from the control group. Fold change = 2<sup>&#x2212;&#x394;&#x394;CT</sup>. Fold change &gt;1 indicates upregulation, &lt;1 indicates downregulation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1535539-g004.tif"/>
</fig>
<p>
<italic>S. mutans</italic> possesses 14 phosphoenolpyruvate-dependent phosphotransferase systems (PTSs) and two ABC transporters, indicating that it can transport various sugars to meet its metabolic needs and adapt to complex and changing environments. Transcriptome analysis indicated a significant reduction in the key gene expression associated with carbohydrate metabolism because of CFS (<xref ref-type="table" rid="T2">
<bold>Tables&#xa0;2</bold>
</xref>, <xref ref-type="table" rid="T3">
<bold>3</bold>
</xref>). Selected genes related to two-component signal transduction systems (<italic>ciaH, ciaR, lytS</italic>, and <italic>lytR</italic>), polyketides/non-ribosomal peptides (<italic>mub gene clust</italic>), acid stress response (<italic>aguA</italic> and <italic>TreR</italic>), quorum sensing gene (<italic>LuxS</italic>), and exopolysaccharide-formation gene (<italic>dexA</italic>) were significantly downregulated and are presented in <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>, which could inhibit oxidative stress and attenuate the virulence of <italic>S. mutans</italic>.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Differentially expressed genes in <italic>S. mutans</italic> upon CFS treatment related to PTSs.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Gene ID</th>
<th valign="middle" align="left">Gene name</th>
<th valign="middle" align="left">log2FoldChange</th>
<th valign="middle" align="left">Gene product description</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">gene-D820_RS08610</td>
<td valign="middle" align="left">D820_RS08610</td>
<td valign="middle" align="left">&#x2212;4.35039416</td>
<td valign="middle" align="left">Metal ABC transporter ATP-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS08600</td>
<td valign="middle" align="left">D820_RS08600</td>
<td valign="middle" align="left">&#x2212;5.299646868</td>
<td valign="middle" align="left">Metal ABC transporter substrate-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS08605</td>
<td valign="middle" align="left">D820_RS08605</td>
<td valign="middle" align="left">&#x2212;4.680503916</td>
<td valign="middle" align="left">Metal ABC transporter permease</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS02670</td>
<td valign="middle" align="left">D820_RS02670</td>
<td valign="middle" align="left">&#x2212;3.320788871</td>
<td valign="middle" align="left">Extracellular solute-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS04680</td>
<td valign="middle" align="left">D820_RS04680</td>
<td valign="middle" align="left">&#x2212;2.095828916</td>
<td valign="middle" align="left">ABC transporter permease/substrate-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS02655</td>
<td valign="middle" align="left">ugpC</td>
<td valign="middle" align="left">&#x2212;2.274872059</td>
<td valign="middle" align="left">sn-glycerol-3-phosphate ABC transporter ATP-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS01050</td>
<td valign="middle" align="left">D820_RS01050</td>
<td valign="middle" align="left">&#x2212;1.381214985</td>
<td valign="middle" align="left">MetQ/NlpA family ABC transporter substrate-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS02665</td>
<td valign="middle" align="left">D820_RS02665</td>
<td valign="middle" align="left">&#x2212;2.14457111</td>
<td valign="middle" align="left">Sugar ABC transporter permease</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS04675</td>
<td valign="middle" align="left">D820_RS04675</td>
<td valign="middle" align="left">&#x2212;1.977690467</td>
<td valign="middle" align="left">ABC transporter ATP-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS05590</td>
<td valign="middle" align="left">msmE</td>
<td valign="middle" align="left">&#x2212;2.511339465</td>
<td valign="middle" align="left">Sugar-binding protein MsmE</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS04570</td>
<td valign="middle" align="left">D820_RS04570</td>
<td valign="middle" align="left">&#x2212;1.468165245</td>
<td valign="middle" align="left">BMP family protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS08355</td>
<td valign="middle" align="left">D820_RS08355</td>
<td valign="middle" align="left">&#x2212;1.831419345</td>
<td valign="middle" align="left">Peptide ABC transporter substrate-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">Gene-D820_RS0109815</td>
<td valign="middle" align="left">D820_RS0109815</td>
<td valign="middle" align="left">&#x2212;1.45009996</td>
<td valign="middle" align="left">Energy-coupling factor transporter ATPase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS08420</td>
<td valign="middle" align="left">D820_RS08420</td>
<td valign="middle" align="left">&#x2212;1.592411347</td>
<td valign="middle" align="left">Amino acid ABC transporter ATP-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS02660</td>
<td valign="middle" align="left">D820_RS02660</td>
<td valign="middle" align="left">&#x2212;2.178411965</td>
<td valign="middle" align="left">Sugar ABC transporter permease</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS05585</td>
<td valign="middle" align="left">D820_RS05585</td>
<td valign="middle" align="left">&#x2212;1.94908875</td>
<td valign="middle" align="left">Sugar ABC transporter permease</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS08415</td>
<td valign="middle" align="left">D820_RS08415</td>
<td valign="middle" align="left">&#x2212;1.353656759</td>
<td valign="middle" align="left">ABC transporter substrate-binding protein/permease</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS05580</td>
<td valign="middle" align="left">D820_RS05580</td>
<td valign="middle" align="left">&#x2212;1.365270344</td>
<td valign="middle" align="left">Carbohydrate ABC transporter permease</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS00140</td>
<td valign="middle" align="left">D820_RS00140</td>
<td valign="middle" align="left">&#x2212;1.273980434</td>
<td valign="middle" align="left">Energy-coupling factor transporter transmembrane protein EcfT</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS07555</td>
<td valign="middle" align="left">D820_RS07555</td>
<td valign="middle" align="left">&#x2212;1.06599486</td>
<td valign="middle" align="left">ABC transporter permease</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS05570</td>
<td valign="middle" align="left">ugpC</td>
<td valign="middle" align="left">&#x2212;1.16129183</td>
<td valign="middle" align="left">sn-glycerol-3-phosphate ABC transporter ATP-binding protein UgpC</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS07560</td>
<td valign="middle" align="left">D820_RS07560</td>
<td valign="middle" align="left">&#x2212;1.092495506</td>
<td valign="middle" align="left">ABC transporter ATP-binding protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS06575</td>
<td valign="middle" align="left">D820_RS06575</td>
<td valign="middle" align="left">&#x2212;1.011033093</td>
<td valign="middle" align="left">ABC transporter ATP-binding protein</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Differentially expressed genes in <italic>S. mutans</italic> upon CFS treatment related to ABC transporters.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Gene ID</th>
<th valign="middle" align="left">Gene name</th>
<th valign="middle" align="left">log2FoldChange</th>
<th valign="middle" align="left">Gene product description</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">gene-D820_RS00965</td>
<td valign="middle" align="left">D820_RS00965</td>
<td valign="middle" align="left">&#x2212;4.232719052</td>
<td valign="middle" align="left">PTS fructose transporter subunit IIA</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS01260</td>
<td valign="middle" align="left">D820_RS01260</td>
<td valign="middle" align="left">&#x2212;3.270871468</td>
<td valign="middle" align="left">PTS sugar transporter subunit IIB</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS01255</td>
<td valign="middle" align="left">D820_RS01255</td>
<td valign="middle" align="left">&#x2212;2.777113939</td>
<td valign="middle" align="left">PTS mannose/fructose/sorbose transporter subunit IIC</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS00970</td>
<td valign="middle" align="left">D820_RS00970</td>
<td valign="middle" align="left">&#x2212;3.736814618</td>
<td valign="middle" align="left">PTS sugar transporter subunit IIB</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS00975</td>
<td valign="middle" align="left">D820_RS00975</td>
<td valign="middle" align="left">&#x2212;3.46228586</td>
<td valign="middle" align="left">PTS sugar transporter subunit IIC</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS01250</td>
<td valign="middle" align="left">D820_RS01250</td>
<td valign="middle" align="left">&#x2212;2.372420573</td>
<td valign="middle" align="left">PTS system mannose/fructose/sorbose family transporter subunit IID</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS09065</td>
<td valign="middle" align="left">D820_RS09065</td>
<td valign="middle" align="left">&#x2212;3.259542925</td>
<td valign="middle" align="left">Fructose-specific PTS transporter subunit EIIC</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS08290</td>
<td valign="middle" align="left">D820_RS08290</td>
<td valign="middle" align="left">&#x2212;2.02278172</td>
<td valign="middle" align="left">PTS ascorbate transporter subunit IIC</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS09070</td>
<td valign="middle" align="left">pfkB</td>
<td valign="middle" align="left">&#x2212;3.715535435</td>
<td valign="middle" align="left">1-Phosphofructokinase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS06470</td>
<td valign="middle" align="left">ptsP</td>
<td valign="middle" align="left">&#x2212;1.76668403</td>
<td valign="middle" align="left">Phosphoenolpyruvate&#x2013;protein phosphotransferase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS09060</td>
<td valign="middle" align="left">D820_RS09060</td>
<td valign="middle" align="left">&#x2212;2.97617044</td>
<td valign="middle" align="left">Fructose PTS transporter subunit IIA</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03005</td>
<td valign="middle" align="left">D820_RS03005</td>
<td valign="middle" align="left">&#x2212;3.082157304</td>
<td valign="middle" align="left">PTS fructose transporter subunit IIB</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS05630</td>
<td valign="middle" align="left">pfkB</td>
<td valign="middle" align="left">&#x2212;1.199569385</td>
<td valign="middle" align="left">1-Phosphofructokinase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03010</td>
<td valign="middle" align="left">D820_RS03010</td>
<td valign="middle" align="left">&#x2212;1.39127042</td>
<td valign="middle" align="left">PTS transporter subunit IIC</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03000</td>
<td valign="middle" align="left">D820_RS03000</td>
<td valign="middle" align="left">&#x2212;2.51286028</td>
<td valign="middle" align="left">PTS sugar transporter subunit IIA</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS02545</td>
<td valign="middle" align="left">celB</td>
<td valign="middle" align="left">&#x2212;1.24228573</td>
<td valign="middle" align="left">PTS cellobiose transporter subunit IIC</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS02525</td>
<td valign="middle" align="left">D820_RS02525</td>
<td valign="middle" align="left">&#x2212;1.420784914</td>
<td valign="middle" align="left">PTS cellobiose transporter subunit IIB</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03015</td>
<td valign="middle" align="left">lacF</td>
<td valign="middle" align="left">&#x2212;1.020431306</td>
<td valign="middle" align="left">PTS lactose transporter subunit IIA</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS02535</td>
<td valign="middle" align="left">D820_RS02535</td>
<td valign="middle" align="left">&#x2212;1.757714575</td>
<td valign="middle" align="left">PTS cellobiose transporter subunit IIA</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS07210</td>
<td valign="middle" align="left">D820_RS07210</td>
<td valign="middle" align="left">&#x2212;1.182133578</td>
<td valign="middle" align="left">PTS sugar transporter subunit IIB</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Differentially expressed genes in <italic>S. mutans</italic> upon CFS treatment related to stress response, quorum sensing gene, and exopolysaccharide formation.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Gene ID</th>
<th valign="middle" align="left">Gene name</th>
<th valign="middle" align="left">log2FoldChange</th>
<th valign="middle" align="left">Gene product description</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">gene-D820_RS04535</td>
<td valign="middle" align="left">ciaH</td>
<td valign="middle" align="left">&#x2212;2.388584358</td>
<td valign="middle" align="left">Three-component system sensor histidine kinase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS04530</td>
<td valign="middle" align="left">ciaR</td>
<td valign="middle" align="left">&#x2212;1.660277218</td>
<td valign="middle" align="left">Three-component system response regulator</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS06890</td>
<td valign="middle" align="left">lytS</td>
<td valign="middle" align="left">&#x2212;1.044404874</td>
<td valign="middle" align="left">Two-component system sensor histidine kinase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS06895</td>
<td valign="middle" align="left">lytR</td>
<td valign="middle" align="left">&#x2212;1.490154315</td>
<td valign="middle" align="left">Two-component system response regulator</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS06900</td>
<td valign="middle" align="left">lrgA</td>
<td valign="middle" align="left">&#x2212;4.847658908</td>
<td valign="middle" align="left">Holin-like protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS06905</td>
<td valign="middle" align="left">lrgB</td>
<td valign="middle" align="left">&#x2212;4.310981884</td>
<td valign="middle" align="left">Antiholin-like protein</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS07385</td>
<td valign="middle" align="left">LuxS</td>
<td valign="middle" align="left">&#x2212;1.164248994</td>
<td valign="middle" align="left">S-ribosylhomocysteine lyase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS00575</td>
<td valign="middle" align="left">dexA</td>
<td valign="middle" align="left">&#x2212;1.002077734</td>
<td valign="middle" align="left">Dextranase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03620</td>
<td valign="middle" align="left">mubB</td>
<td valign="middle" align="left">&#x2212;1.879608552</td>
<td valign="middle" align="left">Mutanobactin A non-ribosomal peptide synthetase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03625</td>
<td valign="middle" align="left">mubC</td>
<td valign="middle" align="left">&#x2212;1.996091508</td>
<td valign="middle" align="left">Mutanobactin A non-ribosomal peptide synthetase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03630</td>
<td valign="middle" align="left">mubD</td>
<td valign="middle" align="left">&#x2212;1.837350518</td>
<td valign="middle" align="left">Mutanobactin A non-ribosomal peptide synthetase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03555</td>
<td valign="middle" align="left">mubY</td>
<td valign="middle" align="left">&#x2212;5.956253759</td>
<td valign="middle" align="left">Mutanobactin A system ABC transporter permease subunit</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03610</td>
<td valign="middle" align="left">mubH</td>
<td valign="middle" align="left">&#x2212;1.182104006</td>
<td valign="middle" align="left">Mutanobactin A polyketide synthase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS03580</td>
<td valign="middle" align="left">mubR</td>
<td valign="middle" align="left">&#x2212;1.400053226</td>
<td valign="middle" align="left">Mutanobactin A biosynthesis transcriptional regulator</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS08310</td>
<td valign="middle" align="left">aguA</td>
<td valign="middle" align="left">&#x2212;1.50902996</td>
<td valign="middle" align="left">Agmatine deiminase</td>
</tr>
<tr>
<td valign="middle" align="left">gene-D820_RS00580</td>
<td valign="middle" align="left">treR</td>
<td valign="middle" align="left">&#x2212;1.242887742</td>
<td valign="middle" align="left">Trehalose operon repressor</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>To confirm the RNA-Seq findings, randomly selected genes underwent quantification through quantitative real-time polymerase chain reaction (qRT-PCR) to assess their transcription levels. As indicated in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>, the genes <italic>lrgB, LuxS, dexA</italic>, and <italic>ldh</italic> showed significant downregulation following treatment with the supernatant, which conformed with the results derived from RNA-seq analysis.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Inhibitory effect of <italic>L. salivarius</italic> on <italic>S. mutans</italic> virulence <italic>in vivo</italic>
</title>
<p>Throughout the entire experimental duration, the rats maintained stable health conditions. Weight gain among all groups showed no statistically significant differences (<xref ref-type="table" rid="T5">
<bold>Table&#xa0;5</bold>
</xref>). As shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>, in the caries-free group, <italic>S. mutans</italic> was not detected, while the levels of <italic>S. mutans</italic> in the caries model, <italic>L. salivarius</italic>, and CFS groups were approximately 4.0 &#xd7; 10<sup>4</sup> CFU/mL after infection for 5 days, demonstrating successful colonization of <italic>S. mutans</italic> within the oral cavities.</p>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Changes in body weight of SD rats during the experiment.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="center">Group</th>
<th valign="middle" colspan="6" align="center">Weight of SD rats at different periods (g)</th>
</tr>
<tr>
<th valign="middle" align="center">28 d</th>
<th valign="middle" align="center">35 d</th>
<th valign="middle" align="center">42 d</th>
<th valign="middle" align="center">49 d</th>
<th valign="middle" align="center">56 d</th>
<th valign="middle" align="center">63 d</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Caries-free</td>
<td valign="middle" align="center">79.1 &#xb1; 1.517</td>
<td valign="middle" align="center">117.1 &#xb1; 0.945</td>
<td valign="middle" align="center">139.2 &#xb1; 1.417</td>
<td valign="middle" align="center">161.6 &#xb1; 0.742</td>
<td valign="middle" align="center">182.1 &#xb1; 0.721</td>
<td valign="middle" align="center">223.3 &#xb1; 1.627</td>
</tr>
<tr>
<td valign="middle" align="center">CFS</td>
<td valign="middle" align="center">77.2 &#xb1; 0.907</td>
<td valign="middle" align="center">116.5 &#xb1; 0.869</td>
<td valign="middle" align="center">139.9 &#xb1; 1.214</td>
<td valign="middle" align="center">60.2 &#xb1; 1.229</td>
<td valign="middle" align="center">178.7 &#xb1; 1.592</td>
<td valign="middle" align="center">220.9 &#xb1; 1.178</td>
</tr>
<tr>
<td valign="middle" align="center">
<italic>L. salivarius</italic>
</td>
<td valign="middle" align="center">80.3 &#xb1; 0.624</td>
<td valign="middle" align="center">117.1 &#xb1; 0.090</td>
<td valign="middle" align="center">138.2 &#xb1; 0.561</td>
<td valign="middle" align="center">160.4 &#xb1; 1.186</td>
<td valign="middle" align="center">179.0 &#xb1; 1.733</td>
<td valign="middle" align="center">219.7 &#xb1; 1.358</td>
</tr>
<tr>
<td valign="middle" align="center">Caries-model</td>
<td valign="middle" align="center">79.6 &#xb1; 1.444</td>
<td valign="middle" align="center">118.5 &#xb1; 1.129</td>
<td valign="middle" align="center">141.3 &#xb1; 1.178</td>
<td valign="middle" align="center">158.8 &#xb1; 1.503</td>
<td valign="middle" align="center">180.6 &#xb1; 1.389</td>
<td valign="middle" align="center">221.1 &#xb1; 1.212</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In order to improve the visibility of caries site on rat molars, micro-CT was used for 3D reconstructions of the mandibular molars, and the enamel was isolated from the complete mandible with a predetermined threshold. Additionally, the relevant sagittal slice of the homorganic molar was extracted for comparative analysis (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). From the complete 3D reconstruction of dental hard tissue, the sagittal slice images of the caries model group were compared with those of the caries-free group, in which it was clear that the enamel (green) areas were discontinuous in the presence of caries. Additionally, to quantitatively assess the results from micro-CT, we calculated and analyzed the enamel volume and mineral density of molar teeth across the various experimental groups. The smaller the enamel volume, the more enamel loss and the more severe the caries. As shown in <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1D, E</bold>
</xref>, the enamel volume and mineral density of the caries model group were obviously less than those in the caries-free group, indicating that the rat caries model was successfully established. The enamel volume and mineral density of the molars treated with CFS were higher than those in the caries-model group and lower than those in the caries-free group (<italic>p</italic> &lt; 0.01). In addition, no significant differences were found in enamel volume and mineral density between the CFS and <italic>L. salivarius</italic> groups.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>In the oral cavity, <italic>S. mutans</italic> and <italic>Lactobacillus</italic> are common microorganisms. Similar to the intestinal microbiota, the oral microbiota is also in a dynamic equilibrium. Once this equilibrium is disrupted, cariogenic microorganisms such as <italic>S. mutans</italic> will become dominant, contributing to the formation of a cariogenic biofilm (<xref ref-type="bibr" rid="B7">Hannig and Hannig, 2009</xref>). Hence, preventing bacterial biofilm formation is vital for maintaining dental health. In previous investigations (<xref ref-type="bibr" rid="B37">Wasfi et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B18">Liang et&#xa0;al., 2023</xref>), the inhibition of <italic>S. mutans</italic> biofilms occurred with the addition of the <italic>L. salivarius</italic> supernatant. The pathogenic mechanisms by which the <italic>L. salivarius</italic> supernatant aids in caries prevention and the potential active substances remain unclear. This study demonstrated that the inhibitory effect of the <italic>L. salivarius</italic> supernatant can reduce the biofilm amount and biofilm activity at different time points. It not only significantly reduced the adhesion of initial biofilms, but also has a potential inhibitory effect on 24-h mature biofilms. The biofilm structure after co-cultivation of CFS and <italic>S. mutans</italic> was significantly loose and sparse, which also has a significant destructive effect on the biofilm structure.</p>
<p>
<italic>Lactobacillus</italic>, an essential category of probiotics, is widely utilized. The growth and reproduction of harmful bacteria can be inhibited by certain compounds, mainly through their metabolites such as organic acids, bacteriocins, and hydrogen peroxide (<xref ref-type="bibr" rid="B22">Liu et&#xa0;al., 2020</xref>). Neutralizing the CFS to pH 6.5 markedly diminished its antimicrobial efficacy, which found that the active components of the CFS could be organic acids or substances that exert an inhibitory effect in acidic environments. The addition of catalase and proteinase K to the CFS resulted in a reduction of its antibacterial activity against <italic>S. mutans</italic>. This indicated that hydrogen peroxide and protein material contribution in antimicrobial activity of the CFS were also important.</p>
<p>Furthermore, the non-targeted LC-MS/MS method was employed to detect the bioactive compounds present in CFS. A mountain of organic acids and derivatives were found from the HMDB analysis. Studies indicated that certain organic acids could impede biofilm formation by certain mechanisms. Among the usual organic acids found in the supernatant of <italic>L. plantarum</italic> CCFM8724, phenolactic acid can significantly suppress the biofilm formation of <italic>S. mutans</italic> and <italic>Candida albicans</italic>. Additionally, phenyllactic acid, a kind of postbiotics, and the secretion of <italic>L. paracasei</italic> ET-22 exhibited significant inhibition of a variety of pathogenic bacteria biofilm formation (<xref ref-type="bibr" rid="B39">Wu et&#xa0;al., 2023</xref>). In the characteristic monosaccharides of CFS from <italic>L. salivarius</italic>, sorbitol had been found to reduce acid production and the amount of bacterial biofilm as well as inhibit the acid production of <italic>S. mutans in vitro</italic> (<xref ref-type="bibr" rid="B31">Takahashi-Abbe et&#xa0;al., 2001</xref>). Sorbitol has been confirmed to decrease the dual-species biofilm formation of <italic>S. mutans</italic> and <italic>C. albicans</italic>, leading to change in biofilm structure and glucan production (<xref ref-type="bibr" rid="B2">Chan et&#xa0;al., 2020</xref>). Therefore, sorbitol was probably an effective substance in CFS of <italic>L. salivarius</italic>. Additionally, we found that the expression of honokiol was upregulated from VIP analysis, which was confirmed to suppress biofilm formation as well as the production of extracellular matrix and lactic acid in <italic>S. mutans</italic> (<xref ref-type="bibr" rid="B26">Ren et&#xa0;al., 2023</xref>).</p>
<p>Sugars are the main carbon source for bacteria, which can be used to produce adenosine triphosphate (ATP) and synthesize various cellular components (such as peptidoglycan, fatty acids, and nucleic acids) and intercellular polysaccharide. The primary means of carbohydrate transport in the dental pathogen <italic>S. mutans</italic> occurs through the glycolysis pathway via the PTS system and ABC transporters. <italic>S. mutans</italic> encodes 14 PTSs and two ABC transporters (<xref ref-type="bibr" rid="B12">Kawada-Matsuo et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B43">Zeng et&#xa0;al., 2017</xref>). Transcriptome analysis of <italic>S. mutans</italic> demonstrated that the expression of major carbohydrate metabolism genes was significantly reduced and influenced by the downregulation of CFS, PTSs for galactitol, cellobiose, fructose, lactose, and mannose. Genes involved in maltose and maltodextrin transport in the ABC transporter system such as <italic>malK, malE</italic>, and <italic>malG</italic> were also downregulated.</p>
<p>Two-component signal transduction system (TCSTS) is a protein phosphorylation signaling pathway widely present in bacteria, which can regulate bacterial gene expression and coordinate various bacterial activities when stimulated by environmental stimuli (<xref ref-type="bibr" rid="B9">Hoch, 2000</xref>). TCSTS generally involves a dimerized transmembrane receptor, specifically histidine kinase (HK), along with a cytoplasmic response regulator (RR). The HK protein, situated in the plasma membrane, is capable of sensing specific environmental stimuli, while the RR protein, located in the cytoplasm, responds to these stimuli by modulating gene expression. In <italic>S. mutans</italic>, numerous TCSTS, such as <italic>VicK/VicR</italic>, <italic>CiaH/CiaR</italic>, <italic>LytST</italic>, and <italic>LiaS/LiaR</italic>, have been identified in the genome of <italic>S. mutans</italic> with substantial supporting lines of evidence that are associated with various functions, including acid tolerance, oxidative stress response, and biofilm formation in <italic>S. mutans</italic> (<xref ref-type="bibr" rid="B15">L&#xe9;vesque et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B20">Liu and Burne, 2009</xref>). In our study, CFS treatment inhibited the gene expression of <italic>ciaH, ciaR, lytS</italic>, and <italic>lytR</italic> in TCSTS. In summary, our results indicate that the CFS&#x2019;s effect on reducing the virulence of <italic>S. mutans</italic> is partially influenced by the downregulation of TCSTS involved in signal transduction.</p>
<p>The primary components of the <italic>S. mutans</italic> biofilm include polysaccharides, extracellular DNA (eDNA), and adhesin proteins (<xref ref-type="bibr" rid="B28">Shanmugam et&#xa0;al., 2020</xref>). In this study, CFS was found to reduce the mRNA expression levels of <italic>lrgA</italic> and <italic>lrgB</italic>, which have a function in the production of eDNA by regulating cell autolysis and the components of membrane vesicles.</p>
<p>Bacterial quorum sensing (QS) is regularly present in Gram-negative and Gram-positive bacteria, which plays an important role in the information exchange among biofilm bacteria under different stress conditions (<xref ref-type="bibr" rid="B33">Valen and Scheie, 2018</xref>). AI-2 molecules, as a messenger molecule of QS, have been identified to play a critical role in the communication processes among <italic>S. mutans</italic>. The protease coded by the gene of <italic>LuxS</italic> is a significant catalyst for the synthesis of AI-2; therefore, the <italic>LuxS</italic> gene serves as a marker for producing this signaling molecule (<xref ref-type="bibr" rid="B27">Schauder et&#xa0;al., 2001</xref>). The LuxS/AI-2 QS system is known to play a role in several essential physiological functions in <italic>S. mutans</italic> (<xref ref-type="bibr" rid="B11">Hu et&#xa0;al., 2018</xref>). Studies indicated that mutations in <italic>LuxS</italic> hindered biofilm formation, decreasing acid tolerance and acid production (<xref ref-type="bibr" rid="B42">Yoshida et&#xa0;al., 2005</xref>). In this article, the gene expression of <italic>luxS</italic> was significantly reduced in the CFS treatment group.</p>
<p>The secondary metabolites of <italic>S. mutans</italic> mainly include bacteriocins and polyketides/non-ribosomal peptides (PKs/NRPs) (<xref ref-type="bibr" rid="B35">Wang et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B40">Xie et&#xa0;al., 2017</xref>). To date, in <italic>S. mutans</italic>, some of the PKs/NRPs that were identified include mutanobactin, mutanocyclin, and mutanofactin, and these metabolites were relatively synthesized by the <italic>mub, muc</italic>, and <italic>muf</italic> gene clusters. These compounds are involved in various functions, including competition between bacterial species, responses to oxidative stress, biofilm formation, and numerous other physiological activities (<xref ref-type="bibr" rid="B38">Wu et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B16">Li et&#xa0;al., 2021</xref>). Most mutanobactin operon-related genes were downregulated. Consequently, the reduced expression of these secondary metabolites could significantly impact the biofilm development of <italic>S. mutans</italic>.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>In conclusion, the transcriptomic analysis provided new insights into the mechanism by which the supernatant of <italic>L. salivarius</italic> inhibits <italic>S. mutans</italic> biofilms, including inhibition of phosphoenolpyruvate-dependent phosphotransferase systems, two ATP-binding cassette transporters, two-component systems, PKs/NRPs, acid stress response, QS, and exopolysaccharide formation. In addition, non-targeted LC-MS/MS analysis was employed to discover a variety of potential active compounds present in the CFS of the <italic>L. salivarius</italic> against <italic>S. mutans</italic> biofilm. The above results provide a theoretical basis for further isolation and purification of the <italic>L. salivarius</italic> supernatant and the production and application of active components, as well as the manner and conformation of molecular docking of active components and <italic>S. mutans</italic> targets. Therefore, it has the potential to act as a therapeutic agent for the prevention and treatment of caries.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the NCBI repository, accession number PRJNA1219341.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by Jinzhou Medical University Animal Protection and Institutional Committee. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>NM: Writing &#x2013; original draft, Data curation, Funding acquisition, Investigation, Methodology, Software, Writing &#x2013; review &amp; editing. WY: Data curation, Investigation, Software, Writing &#x2013; review &amp; editing. BC: Data curation, Investigation, Writing &#x2013; review &amp; editing. MB: Data curation, Investigation, Software, Writing &#x2013; review &amp; editing. YL: Investigation, Software, Writing &#x2013; review &amp; editing. MW: Software, Writing &#x2013; review &amp; editing, Data curation. XY: Methodology, Writing &#x2013; review &amp; editing. JL: Data curation, Writing &#x2013; review &amp; editing. CW: Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing &#x2013; review &amp; editing. LQ: Conceptualization, Methodology, Project administration, Resources, Supervision, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The Technology Innovation Team Program of Liaoning Province Education Department (LJ222410160037), the Young Scholars Program of Liaoning Province Education Department (LJ212410160060), the Applied Basic Research Program of Liaoning Province (2023JH2/101700071), the Applied Basic Research Program of Liaoning Province (2022JH2/101300033), the National Natural Science Foundation of China (U21A2074), and the National Natural Science Foundation of China (62375115).</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alshahrani</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Gregory</surname> <given-names>R. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>
<italic>In vitro</italic> Cariostatic effects of cinnamon water extract on nicotine-induced Streptococcus mutans biofilm</article-title>. <source>BMC Complement Med. Ther.</source> <volume>20</volume>, <fpage>45</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12906-020-2840-x</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ellepola</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Truong</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Balan</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Koo</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Seneviratne</surname> <given-names>C. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Inhibitory effects of xylitol and sorbitol on Streptococcus mutans and Candida albicans biofilms are repressed by the presence of sucrose</article-title>. <source>Arch. Oral. Biol.</source> <volume>119</volume>, <elocation-id>104886</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.archoralbio.2020.104886</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>H. H.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Kuo</surname> <given-names>Y. W.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y. Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>A multi-strain probiotic blend reshaped obesity-related gut dysbiosis and improved lipid metabolism in obese children</article-title>. <source>Front. Nutr.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnut.2022.922993</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cugini</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Shanmugam</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Landge</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Ramasubbu</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The role of exopolysaccharides in oral biofilms</article-title>. <source>J. Dent. Res.</source> <volume>98</volume>, <fpage>739</fpage>&#x2013;<lpage>745</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0022034519845001</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>New strategies and mechanisms for targeting Streptococcus mutans biofilm formation to prevent dental caries: A review</article-title>. <source>Microbiol. Res.</source> <volume>278</volume>, <elocation-id>127526</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micres.2023.127526</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>L.</given-names>
</name>
<name>
<surname>McLean</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Eckert</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kaplan</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Kyme</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>112</volume>, <fpage>7569</fpage>&#x2013;<lpage>7574</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1506207112</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannig</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Hannig</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The oral cavity&#x2013;a key system to understand substratum-dependent bioadhesion on solid surfaces in man</article-title>. <source>Clin. Oral. Investig.</source> <volume>13</volume>, <fpage>123</fpage>&#x2013;<lpage>139</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00784-008-0243-3</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kilpatrick-Liverman</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Santarpia</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>l-Arginine Modifies the Exopolysaccharide Matrix and Thwarts Streptococcus mutans Outgrowth within Mixed-Species Oral Biofilms</article-title>. <source>J. Bacteriol</source> <volume>198</volume>, <fpage>2651</fpage>&#x2013;<lpage>2661</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.00021-16</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoch</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Two-component and phosphorelay signal transduction</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>3</volume>, <fpage>165</fpage>&#x2013;<lpage>170</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1369-5274(00)00070-9</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nie</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Neuropeptide ACP facilitates lipid oxidation and utilization during long-term flight in locusts</article-title>. <source>eLife.</source> <volume>10</volume>, <elocation-id>e65279</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.65279</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>The Impairment of Methyl Metabolism From luxS Mutation of Streptococcus mutans</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.00404</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawada-Matsuo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Oogai</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Komatsuzawa</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Sugar allocation to metabolic pathways is tightly regulated and affects the virulence of streptococcus mutans</article-title>. <source>Genes (Basel)</source> <volume>8</volume>, <fpage>11</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/genes8010011</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xf5;ll-Klais</surname> <given-names>P.</given-names>
</name>
<name>
<surname>M&#xe4;ndar</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Leibur</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Marcotte</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Hammarstr&#xf6;m</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Mikelsaar</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity</article-title>. <source>Oral. Microbiol. Immunol.</source> <volume>20</volume>, <fpage>354</fpage>&#x2013;<lpage>361</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1399-302X.2005.00239.x</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumariya</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Garsa</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Rajput</surname> <given-names>Y. S.</given-names>
</name>
<name>
<surname>Sood</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Akhtar</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Bacteriocins: Classification, synthesis, mechanism of action and resistance development in food spoilage causing bacteria</article-title>. <source>Microb. Pathog.</source> <volume>128</volume>, <fpage>171</fpage>&#x2013;<lpage>177</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2019.01.002</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xe9;vesque</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Mair</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Perry</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Lau</surname> <given-names>P. C.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y. H.</given-names>
</name>
<name>
<surname>Cvitkovitch</surname> <given-names>D. G.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Systemic inactivation and phenotypic characterization of two-component systems in expression of Streptococcus mutans virulence properties</article-title>. <source>Lett. Appl. Microbiol.</source> <volume>45</volume>, <fpage>398</fpage>&#x2013;<lpage>404</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1472-765X.2007.02203.x</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Z. R.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Maboudian</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Mutanofactin promotes adhesion and biofilm formation of cariogenic Streptococcus mutans</article-title>. <source>Nat. Chem. Biol.</source> <volume>17</volume>, <fpage>576</fpage>&#x2013;<lpage>584</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41589-021-00745-2</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Effects of resveratrol on cariogenic virulence properties of Streptococcus mutans</article-title>. <source>BMC Microbiol.</source> <volume>20</volume>, <fpage>99</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12866-020-01761-3</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Exploration of the Main Antibiofilm Substance of Lactobacillus plantarum ATCC 14917 and Its Effect against Streptococcus mutans</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume>, <fpage>1986</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms24031986</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Strategies for Streptococcus mutans biofilm dispersal through extracellular polymeric substances disruption</article-title>. <source>Mol. Oral. Microbiol.</source> <volume>37</volume>, <fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/omi.12355</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Burne</surname> <given-names>R. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Multiple two-component systems modulate alkali generation in Streptococcus gordonii in response to environmental stresses</article-title>. <source>J. Bacteriol</source> <volume>191</volume>, <fpage>7353</fpage>&#x2013;<lpage>7362</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.01053-09</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Loss of CEP70 function affects acrosome biogenesis and flagella formation during spermiogenesis</article-title>. <source>Cell Death Dis.</source> <volume>12</volume>, <fpage>478</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-021-03755-z</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zhai</surname> <given-names>Q.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier</article-title>. <source>Microb. Cell Fact</source> <volume>19</volume>, <fpage>23</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12934-020-1289-4</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mani-Lopez</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Arrioja-Breton</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Lopez-Malo</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The impacts of antimicrobial and antifungal activity of cell-free supernatants from lactic acid bacteria <italic>in vitro</italic> and foods</article-title>. <source>Compr. Rev. Food Sci. Food Saf.</source> <volume>21</volume>, <fpage>604</fpage>&#x2013;<lpage>641</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/1541-4337.12872</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulla</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hegde</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Koshy</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mulla</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Effect of probiotic lactobacillus salivarius on peri-implantitis pathogenic bacteria: an <italic>in vitro</italic> study</article-title>. <source>Cureus</source> <volume>13</volume>, <elocation-id>e20808</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7759/cureus.20808</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niranjan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Patil</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Dubey</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Lochab</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Priyadarshini</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Small cyclic dipeptide produced by Lactobacillus rhamnosus with anti-biofilm properties against Streptococcus mutans biofilm</article-title>. <source>Biofilm</source> <volume>8</volume>, <elocation-id>100237</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bioflm.2024.100237</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zuo</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>A Chinese herb preparation, honokiol, inhibits Streptococcus mutans biofilm formation</article-title>. <source>Arch. Oral. Biol.</source> <volume>147</volume>, <elocation-id>105610</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.archoralbio.2022.105610</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schauder</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Shokat</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Surette</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Bassler</surname> <given-names>B. L.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule</article-title>. <source>Mol. Microbiol.</source> <volume>41</volume>, <fpage>463</fpage>&#x2013;<lpage>476</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02532.x</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shanmugam</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Sarveswari</surname> <given-names>H. B.</given-names>
</name>
<name>
<surname>Udayashankar</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Swamy</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Pudipeddi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Shanmugam</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Guardian genes ensuring subsistence of oral Streptococcus mutans</article-title>. <source>Crit. Rev. Microbiol.</source> <volume>46</volume>, <fpage>475</fpage>&#x2013;<lpage>491</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/1040841x.2020.1796579</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon-Soro</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mira</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Solving the etiology of dental caries</article-title>. <source>Trends Microbiol.</source> <volume>23</volume>, <fpage>76</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tim.2014.10.010</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The inhibitory effects of ficin on streptococcus mutans biofilm formation</article-title>. <source>BioMed. Res. Int.</source> <volume>2021</volume>, <elocation-id>6692328</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2021/6692328</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi-Abbe</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Abbe</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Tamazawa</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yamada</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Inhibitory effect of sorbitol on sugar metabolism of Streptococcus mutans <italic>in vitro</italic> and on acid production in dental plaque <italic>in vivo</italic>
</article-title>. <source>Oral. Microbiol. Immunol.</source> <volume>16</volume>, <fpage>94</fpage>&#x2013;<lpage>99</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1034/j.1399-302x.2001.016002094.x</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vahedi Shahandashti</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kasra Kermanshahi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ghadam</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The inhibitory effect of bacteriocin produced by Lactobacillus acidophilusATCC 4356 and Lactobacillus plantarum ATCC 8014 on planktonic cells and biofilms of Serratia marcescens</article-title>. <source>Turk J. Med. Sci.</source> <volume>46</volume>, <fpage>1188</fpage>&#x2013;<lpage>1196</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3906/sag-1505-51</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Scheie</surname> <given-names>A. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Biofilms and their properties</article-title>. <source>Eur. J. Oral. Sci.</source> <volume>126 Suppl 1</volume>, <fpage>13</fpage>&#x2013;<lpage>18</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/eos.12425</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Zyl</surname> <given-names>W. F.</given-names>
</name>
<name>
<surname>Deane</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Dicks</surname> <given-names>L. M. T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria</article-title>. <source>Gut Microbes</source> <volume>12</volume>, <elocation-id>1831339</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2020.1831339</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Du</surname> <given-names>L.</given-names>
</name>
<name>
<surname>You</surname> <given-names>J.</given-names>
</name>
<name>
<surname>King</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Cichewicz</surname> <given-names>R. H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Fungal biofilm inhibitors from a human oral microbiome-derived bacterium</article-title>. <source>Org Biomol Chem.</source> <volume>10</volume>, <fpage>2044</fpage>&#x2013;<lpage>2050</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c2ob06856g</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wasfi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Abd-El-Rahman</surname> <given-names>O. A.</given-names>
</name>
<name>
<surname>Mansour</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Hanora</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Hashem</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Ashour</surname> <given-names>M. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections</article-title>. <source>Indian J. Med. Microbiol.</source> <volume>30</volume>, <fpage>76</fpage>&#x2013;<lpage>80</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/0255-0857.93044</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wasfi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Abd-El-Rahman</surname> <given-names>O. A.</given-names>
</name>
<name>
<surname>Zafer</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Ashour</surname> <given-names>H. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans</article-title>. <source>J. Cell Mol. Med.</source> <volume>22</volume>, <fpage>1972</fpage>&#x2013;<lpage>1983</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcmm.13496</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cichewicz</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Roe</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Ferretti</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Genomic island TnSmu2 of Streptococcus mutans harbors a nonribosomal peptide synthetase-polyketide synthase gene cluster responsible for the biosynthesis of pigments involved in oxygen and H2O2 tolerance</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>76</volume>, <fpage>5815</fpage>&#x2013;<lpage>5826</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aem.03079-09</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Guang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Mu</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Recent development of phenyllactic acid: physicochemical properties, biotechnological production strategies and applications</article-title>. <source>Crit. Rev. Biotechnol.</source> <volume>43</volume>, <fpage>293</fpage>&#x2013;<lpage>308</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/07388551.2021.2010645</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Secondary metabolites from Streptococcus mutans and their ecological roles in dental biofilm</article-title>. <source>Sheng Wu Gong Cheng Xue Bao</source> <volume>33</volume>, <fpage>1547</fpage>&#x2013;<lpage>1554</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.13345/j.cjb.170046</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeun</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Effect of a double-coated probiotic formulation on functional constipation in the elderly: a randomized, double blind, controlled study</article-title>. <source>Arch. Pharm. Res.</source> <volume>38</volume>, <fpage>1345</fpage>&#x2013;<lpage>1350</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12272-014-0522-2</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ansai</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Takehara</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kuramitsu</surname> <given-names>H. K.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>LuxS-based signaling affects Streptococcus mutans biofilm formation</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>71</volume>, <fpage>2372</fpage>&#x2013;<lpage>2380</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aem.71.5.2372-2380.2005</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Chakraborty</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Farivar</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Burne</surname> <given-names>R. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Coordinated Regulation&#xa0;of the EII(Man) and fruRKI Operons of Streptococcus mutans by Global and Fructose-Specific Pathways</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>83</volume>, <elocation-id>e01403-17</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aem.01403-17</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Vu</surname> <given-names>V. H.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Inhibition of Streptococcus mutans Biofilm Formation and Virulence by Lactobacillus plantarum K41 Isolated From Traditional Sichuan Pickles</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2020.00774</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>Z.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Preventive effects of probiotics on dental&#xa0;caries <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>BMC Oral. Health</source> <volume>24</volume>, <fpage>915</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12903-024-04703-x</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Postbiotics Derived from L. paracasei ET-22 Inhibit the Formation of S. mutans Biofilms and Bioactive Substances: An Analysis</article-title>. <source>Molecules</source> <volume>28</volume>, <fpage>1236</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules28031236</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>